Editorial: Unravelling the role of CB2r in neuropsychiatric diseases

por Onaivi, Emmanuel S.
Publicado 2023

Cannabis for COVID-19: can cannabinoids quell the cytokine storm?

por Onaivi, Emmanuel Shan, Sharma, Venkatanarayanan
Publicado 2020

Endocannabinoid system components as potential neuroimmune therapeutic targets in tinnitus

por Bhat, Vishweshwara, Onaivi, Emmanuel Shan, Sharma, Venkatanarayanan
Publicado 2023

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders

por Kibret, Berhanu Geresu, Ishiguro, Hiroki, Horiuchi, Yasue, Onaivi, Emmanuel S.
Publicado 2022

Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders

por Ishiguro, Hiroki, Kibret, Berhanu Geresu, Horiuchi, Yasue, Onaivi, Emmanuel S.
Publicado 2022

Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation

por Kibret, Berhanu Geresu, Canseco-Alba, Ana, Onaivi, Emmanuel S., Engidawork, Ephrem
Publicado 2023

Neuronal cell adhesion molecule regulating neural systems underlying addiction

por Ishiguro, Hiroki, Miyake, Kunio, Tabata, Koichi, Mochizuki, Chiaki, Sakurai, Takeshi, Onaivi, Emmanuel S.
Publicado 2018

Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects

por Liu, Qing-Rong, Canseco-Alba, Ana, Liang, Ying, Ishiguro, Hiroki, Onaivi, Emmanuel S.
Publicado 2020

PREFACE

por Ali, Syed F, Kim, Hyoung-Chun, Koob, George, Onaivi, Emmanuel, Kuhar, Michael J
Publicado 2011

Cannabinoid CB2 Receptor Gene and Environmental Interaction in the Development of Psychiatric Disorders

por Ishiguro, Hiroki, Horiuchi, Yasue, Tabata, Koichi, Liu, Qing-Rong, Arinami, Tadao, Onaivi, Emmanuel S.
Publicado 2018

Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA

por Musa, Aurora, Simola, Nicola, Piras, Gessica, Caria, Francesca, Onaivi, Emmanuel Shan, De Luca, Maria Antonietta
Publicado 2020

Involvement of CB2 Receptors in the Neurobehavioral Effects of Catha Edulis (Vahl) Endl. (Khat) in Mice

por Geresu, Berhanu, Canseco-Alba, Ana, Sanabria, Branden, Lin, Zhicheng, Liu, Qing-Rong, Onaivi, Emmanuel S., Engidawork, Ephrem
Publicado 2019

Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder

por Canseco-Alba, Ana, Sanabria, Branden, Hammouda, Mariam, Bernadin, Rollanda, Mina, Marizel, Liu, Qing-Rong, Onaivi, Emmanuel S.
Publicado 2022

Acute cannabidiol treatment enhances social interaction in adult male mice

por Ferreira, Livia F., Pathapati, Nikhita, Schultz, Stephen T., Nunn, Mary C., Pierce, Bethany L., Sanchez, Yatzil R., Murrell, Meredith D., Ginsburg, Brett C., Onaivi, Emmanuel S., Gould, Georgianna G.
Publicado 2023

Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects

por Onaivi, Emmanuel S., Ishiguro, Hiroki, Gong, Jian-Ping, Patel, Sejal, Meozzi, Paul A., Myers, Lester, Perchuk, Alex, Mora, Zoila, Tagliaferro, Patricia A., Gardner, Eileen, Brusco, Alicia, Akinshola, B. Emmanuel, Hope, Bruce, Lujilde, Javier, Inada, Toshiya, Iwasaki, Shinya, Macharia, David, Teasenfitz, Lindsey, Arinami, Tadao, Uhl, George R.
Publicado 2008

Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference

por Liu, Qing-Rong, Canseco-Alba, Ana, Zhang, Hai-Ying, Tagliaferro, Patricia, Chung, Monika, Dennis, Eugene, Sanabria, Branden, Schanz, Norman, Escosteguy-Neto, Joao Carlos, Ishiguro, Hiroki, Lin, Zhicheng, Sgro, Susan, Leonard, Claire M., Santos-Junior, Jair Guilherme, Gardner, Eliot L., Egan, Josephine M., Lee, Jeung Woon, Xi, Zheng-Xiong, Onaivi, Emmanuel S.
Publicado 2017